Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Caraco Pharmaceutical Ltd. (“Caraco” or the “Company”) (AMEX: CPD) relating to the proposed acquisition by Sun Pharmaceutical Industries (‘Sun”).

Under the terms of the offer, Caraco shareholders would receive $4.75 in cash for each share of Caraco stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law. The transaction appears to be unfair, in part, given that Caraco stock was trading at $5.86 a share as recently as October 18, 2010 and was trading at $6.83 a share on April 28, 2010.

If you own shares of Caraco and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/249-cpd-caraco-pharmaceuticals-laboratories-ltd.html, or by calling toll free 877-LEGAL-90.

Caraco (AMEX:CPD)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Caraco
Caraco (AMEX:CPD)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Caraco